deflazacort has been researched along with Cirrhosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benson, DW; Fleck, RJ; Gao, Z; Hor, KN; Jefferies, JL; Mazur, W; Sticka, JJ; Tandon, A; Taylor, MD; Towbin, JA; Villa, CR; Wong, BL | 1 |
| Barbin, IC; Ferretti, R; Marques, MJ; Oggiam, DS; Santo Neto, H | 1 |
| Albano, M; Bagnasco, M; Passalacqua, G; Pronzato, C; Scordamaglia, A; Torre, G | 1 |
3 other study(ies) available for deflazacort and Cirrhosis
| Article | Year |
|---|---|
Myocardial fibrosis burden predicts left ventricular ejection fraction and is associated with age and steroid treatment duration in duchenne muscular dystrophy.
Topics: Adolescent; Adult; Age Factors; Child; Disease Progression; Fibrosis; Glucocorticoids; Heart; Humans; Magnetic Resonance Imaging; Male; Muscular Dystrophy, Duchenne; Myocardium; Prednisone; Pregnenediones; Retrospective Studies; Stroke Volume; Young Adult | 2015 |
Long-term therapy with deflazacort decreases myocardial fibrosis in mdx mice.
Topics: Animals; Anti-Inflammatory Agents; Fibrosis; Heart; Mice; Mice, Inbred mdx; Muscular Dystrophy, Animal; Myocardium; Pregnenediones; Time Factors | 2009 |
Fibrous invasive (Riedel's) thyroiditis with critical response to steroid treatment.
Topics: Adult; Anti-Inflammatory Agents; Chronic Disease; Female; Fibrosis; Humans; Immunosuppressive Agents; Pregnenediones; Radiography; Remission Induction; Thyroid Gland; Thyroiditis, Autoimmune | 1995 |